✦ LIBER ✦

2.220 Duodenal levodopa infusion for advanced Parkinson's disease: 24-month treatment outcome

✍ Scribed by F. Mancini; A. Antonini; M. Canesi; L. Manfredi; M. Zibetti; I.U. Isaias; R. Zangaglia; C. Pacchetti; L. Lopiano; M. Dal Fante; G. Pezzoli

Book ID: 117752871
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 54 KB
Volume: 13
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(08)70631-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Duodenal levodopa infusion for advanced

Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome

✍ Angelo Antonini; Ioannis U. Isaias; Margherita Canesi; Maurizio Zibetti; Frances 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract We assessed prospectively clinical and quality of life changes in 9 patients with Parkinson's disease (PD; H&Y ≥ 3) with severe motor fluctuations and dyskinesia who started continuous daily levodopa duodenal infusion through percutaneous endoscopic gastrostomy. Seven patients completed

Duodenal levodopa infusion for the treat

Duodenal levodopa infusion for the treatment of Parkinson’s disease

✍ Samanta, Johan; Hauser, Robert A 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 307 KB

2.256 SYMPTOMATIC NEUROPATHY IN PARKINSO

2.256 SYMPTOMATIC NEUROPATHY IN PARKINSON'S DISEASE PATIENTS DURING DUODENAL LEVODOPA INFUSION TREATMENT

✍ F. Mancini; D. Calandrella; M. Del Fante; G. Riboldazzi; R. Zangaglia; C. Pacche 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Effect and safety of duodenal levodopa i

Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care

✍ A. Antonini, P. Odin, L. opiano, V. Tomantschger… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 212 KB

Parkinson’s disease: recent development

Parkinson’s disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion

✍ Olof Sydow 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PND27 COST UTILITY ANALYSIS OF ORPHAN DR

PND27 COST UTILITY ANALYSIS OF ORPHAN DRUGS: CASE STUDY OF DUODENAL LEVODOPA INFUSION VERSUS STANDARD TREATMENT IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE IN SWEDEN

✍ M Willis; B Gradl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB